Hengkang Medical Group Co., Ltd. (002219.SZ)
CNY 2.82
(-1.74%)
CNY 2.82
(-1.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.59 Billion | 3.15 Billion | 3.01 Billion | 2.8 Billion | 3.68 Billion | 3.83 Billion |
| Cost of Revenue | 2.51 Billion | 2.16 Billion | 2.2 Billion | 2.01 Billion | 2.71 Billion | 3.01 Billion |
| Gross Profit | 1.07 Billion | 992.63 Million | 807.71 Million | 790.74 Million | 972.51 Million | 826.58 Million |
| Operating Expenses | 1.04 Billion | 691.39 Million | 721.42 Million | 564.97 Million | 851.68 Million | 784.41 Million |
| Selling, General and Administrative Expenses | 833.73 Million | 373.05 Million | 398.44 Million | 306.14 Million | 466.03 Million | 330.52 Million |
| Research and Development Expenses | 27.71 Million | 237.88 Thousand | 444.48 Thousand | 296.93 Thousand | 1.29 Million | 8.26 Million |
| Other Expenses | 133.56 Million | 318.1 Million | 322.53 Million | 258.53 Million | 384.35 Million | -37 Million |
| Cost and Expenses | 3.55 Billion | 2.85 Billion | 2.92 Billion | 2.58 Billion | 3.56 Billion | 3.79 Billion |
| Operating Income | 126.75 Million | 358.04 Million | 153.94 Million | 198.09 Million | 120.83 Million | -1.29 Billion |
| Interest Expense | 123.53 Million | 142.58 Million | 230.03 Million | 136.61 Million | 344.61 Million | 344.16 Million |
| Income Tax Expense | -28.65 Million | 23.18 Million | 4.91 Million | 52.5 Million | 60.5 Million | 53.77 Million |
| Earnings before Tax | 10.25 Million | 187.48 Million | -362.38 Million | 9.99 Million | -2.43 Billion | -1.33 Billion |
| Net Income | 30.77 Million | 156.12 Million | -367.3 Million | -42.51 Million | -2.49 Billion | -1.41 Billion |
| Earnings Per Share Basic | 0.01 | 0.05 | -0.20 | -0.02 | -1.34 | -0.76 |
| Earnings Per Share Diluted | 0.01 | 0.05 | -0.20 | -0.02 | -1.34 | -0.76 |
| Weighted Average Shares Outstanding | 3.38 Billion | 3.26 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.38 Billion | 3.26 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion |
| Gross Margin | 0.30 | 0.31 | 0.27 | 0.28 | 0.26 | 0.22 |
| EBIT Margin | 0.10 | 0.17 | 0.11 | 0.13 | -0.06 | 0.01 |
| Profit Margin | 0.01 | 0.05 | -0.12 | -0.02 | -0.68 | -0.37 |
| EBITDA | 348.09 Million | 496.69 Million | 30.93 Million | 328.98 Million | -1.94 Billion | -673.81 Million |
| Earnings Before Tax Margin | 0.04 | 0.11 | 0.05 | 0.07 | 0.03 | -0.34 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 860.5 Million | 950.37 Million | 862.83 Million | 3.56 Billion | 1.07 Billion | 900.35 Million |
| Cost of Revenue | 620.19 Million | 695.14 Million | 614.33 Million | 2.57 Billion | 787.94 Million | 660.93 Million |
| Gross Profit | 240.31 Million | 255.23 Million | 248.5 Million | 988.59 Million | 287.9 Million | 239.41 Million |
| Operating Expenses | 194.55 Million | 188.62 Million | 175.73 Million | 861.84 Million | 278.34 Million | 203.17 Million |
| Selling, General and Administrative Expenses | 374.91 Million | 185.59 Million | 170.83 Million | - | 257.15 Million | 355.13 Million |
| Research and Development Expenses | 1.11 Million | 3.03 Million | 3.37 Million | - | 20.8 Million | 6.08 Million |
| Other Expenses | -181.47 Million | -396.8 Thousand | -3.83 Million | -401.74 Thousand | -391.74 Thousand | -6.67 Million |
| Cost and Expenses | 814.74 Million | 883.77 Million | 790.07 Million | 3.44 Billion | 1.06 Billion | 864.1 Million |
| Operating Income | 2.21 Million | 66.6 Million | 32 Million | 126.75 Million | 9.55 Million | -25.87 Million |
| Interest Expense | 30.76 Million | 30.58 Million | 32.15 Million | 120.64 Million | 33.59 Million | 33.32 Million |
| Income Tax Expense | 2.71 Million | 3.2 Million | 3.02 Million | -28.65 Million | -24.11 Million | -8.24 Million |
| Earnings before Tax | -3.1 Million | 40.57 Million | 28.16 Million | 10.28 Million | -21.33 Million | -32.54 Million |
| Net Income | -7.35 Million | 35.73 Million | 24.4 Million | 30.77 Million | -2.64 Million | -23.58 Million |
| Earnings Per Share Basic | -0.00 | 0.01 | 0.01 | - | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.00 | 0.01 | 0.01 | - | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 3.4 Billion | 3.41 Billion | 3.38 Billion | 3.38 Billion | 3.41 Billion | 3.38 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.4 Billion | 3.41 Billion | 3.38 Billion | 3.38 Billion | 3.41 Billion | 3.38 Billion |
| Gross Margin | 0.28 | 0.27 | 0.29 | 0.28 | 0.27 | 0.27 |
| EBIT Margin | 0.03 | 0.12 | 0.08 | - | 0.08 | 0.04 |
| Profit Margin | -0.01 | 0.04 | 0.03 | 0.01 | -0.00 | -0.03 |
| EBITDA | 27.66 Million | 116.68 Million | 69.98 Million | - | 81.47 Million | 32.08 Million |
| Earnings Before Tax Margin | 0.00 | 0.07 | 0.04 | 0.04 | 0.01 | -0.03 |
NHLPF
JALL3
1301
ROMI3
FLNC
AN